Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

HudsonTRT

Take control of your health journey with HudsonTRT.

Legal

HIPAA Notice
Privacy Policy
Returns & Refund Policy
Terms of Use
CCPA Opt-Out
SMS Terms and Conditions

Company

About
Contact
FAQ

Medications are only issued when clinically appropriate following a provider evaluation. Hudson Vitality LLC, DBA HudsonTRT, does not manufacture compounded medications, and the appearance and labeling of the product you receive may differ from images shown on this site.

Hudson Vitality LLC, DBA HudsonTRT, operates as a management services organization connecting patients with independently licensed healthcare providers who deliver care through MDI (MD Integrations). HudsonTRT does not itself dispense medication or provide medical services, and all clinical decisions are made solely by independent providers. Submitting payment does not guarantee that a prescription will be issued or that medication will be dispensed; any prescription is based solely on the professional judgment of your healthcare provider. See our Terms of Use for details.

Information on this site is for general informational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider with questions about your health. This site advertises healthcare services generally, not any specific prescription medication.

Disclaimer: FDA-approved brand-name medications, including Wegovy® and Ozempic®, are manufactured and distributed exclusively by Novo Nordisk®. Mounjaro® and Zepbound® are manufactured and distributed exclusively by Eli Lilly and Company®. HudsonTRT is not affiliated with, endorsed by, or sponsored by any of these companies or their products.

Compounded medications referenced on this site are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. They are prepared by licensed compounding pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits compounding based on a valid, patient-specific prescription from a licensed healthcare provider.